Brain changes associated with thromboxane receptor antagonist SQ 29,548 treatment in a mouse model

about

Brain changes associated with thromboxane receptor antagonist SQ 29,548 treatment in a mouse model

Item

http://www.wikidata.org/entity/Q35772240

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Brain changes associated with ...... 548 treatment in a mouse model

@ast

Brain changes associated with ...... 548 treatment in a mouse model

@en

type

Item

label

Brain changes associated with ...... 548 treatment in a mouse model

@ast

Brain changes associated with ...... 548 treatment in a mouse model

@en

prefLabel

Brain changes associated with ...... 548 treatment in a mouse model

@ast

Brain changes associated with ...... 548 treatment in a mouse model

@en

P1476

Brain changes associated with ...... 548 treatment in a mouse model

@en

P2093

Andrew A Rebel

http://www.w3.org/2001/XMLSchema#string

Atreyi Ghatak

http://www.w3.org/2001/XMLSchema#string

Colin K Combs

http://www.w3.org/2001/XMLSchema#string

Kendra L Puig

http://www.w3.org/2001/XMLSchema#string

Mikhail Y Golovko

http://www.w3.org/2001/XMLSchema#string

Siri A Urquhart

http://www.w3.org/2001/XMLSchema#string

Stephen A Brose

http://www.w3.org/2001/XMLSchema#string

P2860

The molecular neurobiology of depression

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor

Depression: a new animal model sensitive to antidepressant treatments

Behavioral despair in mice: a primary screening test for antidepressants

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs

2D-DIGE proteome analysis on the platelet proteins of patients with major depression.

Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease?

P304

1279-1292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JNR.23578

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25703023

http://www.w3.org/2001/XMLSchema#string

P932

4478107

http://www.w3.org/2001/XMLSchema#string